QQ客服 官方微博 反馈留言

	Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial
	Held, Claes; Hylek, Elaine M.; Alexander, John H.; Hanna, Michael; Lopes, Renato D.; Wojdyla, Daniel M.; Thomas, Laine; Al-Khalidi, Hussein; Alings, Marco; Xavier, Dennis
	2015
卷号	36期号:20页码:1264-1272
关键词	Atrial fibrillation Bleeding Factor Xa inhibitor
ISSN号	0195-668X
DOI	10.1093/eurheartj/ehu463
URL标识	查看原文
收录类别	SCIE ; PUBMED ; ESI高被引论文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6386904
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Held, Claes,Hylek, Elaine M.,Alexander, John H.,et al. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial[J],2015,36(20):1264-1272.
APA	Held, Claes.,Hylek, Elaine M..,Alexander, John H..,Hanna, Michael.,Lopes, Renato D..,...&Wallentin, Lars.(2015).Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.,36(20),1264-1272.
MLA	Held, Claes,et al."Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial".36.20(2015):1264-1272.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。